These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37909445)

  • 1. [Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland].
    Olafsson RP; Kvaran K; Ketilsdottir K; Hallgrimsdottir K; Sigurdsson EL; Sigurdsson E
    Laeknabladid; 2023 Nov; 109(11):495-503. PubMed ID: 37909445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of Australian psychiatrists' and psychiatry trainees' knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders.
    Grover C; Monds L; Montebello M
    Australas Psychiatry; 2023 Jun; 31(3):329-335. PubMed ID: 36753675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
    Davis AK; Agin-Liebes G; España M; Pilecki B; Luoma J
    J Psychoactive Drugs; 2022; 54(4):309-318. PubMed ID: 34468293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of European psychiatrists on psychedelics: a qualitative study.
    Žuljević MF; Breški N; Kaliterna M; Hren D
    Front Psychiatry; 2024; 15():1411234. PubMed ID: 38855648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
    Corrigan K; Haran M; McCandliss C; McManus R; Cleary S; Trant R; Kelly Y; Ledden K; Rush G; O'Keane V; Kelly JR
    Ir J Med Sci; 2022 Jun; 191(3):1385-1397. PubMed ID: 34131812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.
    Nadeem Z; Parker S; McGovern H; Oestreich LK
    Aust N Z J Psychiatry; 2024 Oct; 58(10):904-913. PubMed ID: 38907608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of European psychiatrists on psychedelics: a cross-sectional survey study.
    Žuljević MF; Hren D; Storman D; Kaliterna M; Duplančić D
    Sci Rep; 2024 Aug; 14(1):18716. PubMed ID: 39134670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery.
    VanderZwaag B; Garcia-Romeu A; Garcia-Barrera MA
    Ther Adv Psychopharmacol; 2024; 14():20451253241264812. PubMed ID: 39132012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics.
    Kucsera A; Suppes T; Haug NA
    Clin Psychol Psychother; 2023; 30(6):1369-1379. PubMed ID: 37394242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attitudes on Psychedelics in a Sample of Croatian Mental Health Professionals: A Cross-Sectional National Survey Study.
    Mastelić T; Borovina Marasović T; Žuljević MF; Sučević Ercegovac M; Kaliterna M; Pleić N; Vukorepa D; Topić J; Žuljan Cvitanović M; Lasić D; Uglešić B; Kozina S; Glavina T
    J Psychoactive Drugs; 2024 Jun; ():1-10. PubMed ID: 38934459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists.
    Berger JJ; Fitzgerald PB
    Australas Psychiatry; 2023 Apr; 31(2):190-194. PubMed ID: 36779819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.
    Song-Smith C; Jacobs E; Rucker J; Saint M; Cooke J; Schlosser M
    BMJ Open; 2024 Mar; 14(3):e083595. PubMed ID: 38485474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Attitudes of Mental Health Experts Towards Psilocybin].
    Schmidt C; Wolff M; Gründer G; Jungaberle H
    Fortschr Neurol Psychiatr; 2023 Mar; 91(3):80-87. PubMed ID: 35724682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beliefs about the helpfulness of interventions for mental disorders: a comparison of general practitioners, psychiatrists and clinical psychologists.
    Jorm AF; Korten AE; Jacomb PA; Rodgers B; Pollitt P
    Aust N Z J Psychiatry; 1997 Dec; 31(6):844-51. PubMed ID: 9483257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
    Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
    Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction specialists' attitudes toward psychedelics: A National Survey.
    Kim A; Suzuki J
    Am J Addict; 2023 Nov; 32(6):606-609. PubMed ID: 37550848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities.
    Rosenbaum D; Weissman C; Anderson T; Petranker R; Dinh-Williams LA; Hui K; Hapke E
    J Psychopharmacol; 2020 Jun; 34(6):612-622. PubMed ID: 32108529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.